NO20073167L - Skjaerbeskyttende midler for isolering ved mikrofiltrering - Google Patents

Skjaerbeskyttende midler for isolering ved mikrofiltrering

Info

Publication number
NO20073167L
NO20073167L NO20073167A NO20073167A NO20073167L NO 20073167 L NO20073167 L NO 20073167L NO 20073167 A NO20073167 A NO 20073167A NO 20073167 A NO20073167 A NO 20073167A NO 20073167 L NO20073167 L NO 20073167L
Authority
NO
Norway
Prior art keywords
microfiltration
insulation
protection agents
cutting protection
diafiltration
Prior art date
Application number
NO20073167A
Other languages
English (en)
Inventor
James Pierce
Enda Moran
Original Assignee
Wyeth Res Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36791010&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073167(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Res Ireland Ltd filed Critical Wyeth Res Ireland Ltd
Publication of NO20073167L publication Critical patent/NO20073167L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/16—Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/147—Microfiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/12—Addition of chemical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/16—Flow or flux control
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Housing For Livestock And Birds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Tilsetningen av buffer til en isoleringsstrøm under diafiltrering kan forårsake økt turbiditet og ha andre uønskede effekter, inklusivt begrenset produktgjenvinning. Fremgangsmåter og sammensetninger med relasjon til anvendelsen av en ikke-ionisk surfaktant for forbedret diafiltrering er beskrevet.
NO20073167A 2005-01-25 2007-06-22 Skjaerbeskyttende midler for isolering ved mikrofiltrering NO20073167L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64718405P 2005-01-25 2005-01-25
PCT/IB2006/001231 WO2006087643A2 (en) 2005-01-25 2006-01-24 Method for diafiltration

Publications (1)

Publication Number Publication Date
NO20073167L true NO20073167L (no) 2007-09-27

Family

ID=36791010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073167A NO20073167L (no) 2005-01-25 2007-06-22 Skjaerbeskyttende midler for isolering ved mikrofiltrering

Country Status (19)

Country Link
US (1) US7906024B2 (no)
EP (1) EP1841474A2 (no)
JP (1) JP5312799B2 (no)
KR (1) KR101337311B1 (no)
CN (1) CN101107022B (no)
AR (1) AR057263A1 (no)
AU (1) AU2006215313B2 (no)
BR (1) BRPI0607269A2 (no)
CA (1) CA2594580C (no)
CR (1) CR9212A (no)
GT (1) GT200600027A (no)
IL (1) IL184247A (no)
MX (1) MX2007008777A (no)
NI (1) NI200700153A (no)
NO (1) NO20073167L (no)
PE (1) PE20060958A1 (no)
RU (1) RU2442822C2 (no)
TW (1) TW200634145A (no)
WO (1) WO2006087643A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932858B2 (en) * 2008-03-07 2015-01-13 Corning Incorporated Modified polysaccharide for cell culture and release
CA2750263C (en) * 2009-01-21 2018-03-20 Smartflow Technologies, Inc. Optimization of separation for viscous suspensions
CN102413908B (zh) * 2009-04-29 2015-09-23 巴斯夫欧洲公司 借助膜过滤调节催化剂的方法
SG182611A1 (en) * 2010-01-22 2012-08-30 Lonza Walkersville Inc High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration
SG11201600392PA (en) * 2013-07-19 2016-02-26 Circle Technologies Inc Systems and methods for bioprocess analysis
MX2019000882A (es) * 2016-07-21 2019-08-12 Spark Therapeutics Inc Metodos de alta recuperacion escalables para una alta produccion de vector viral adenoasociado recombinante (raav) y vectores virales adenoasociados recombinantes (raav) producidos de este modo.
EP4189064A1 (en) * 2020-07-30 2023-06-07 Amgen Inc. Cell culture media and methods of making and using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
DE3515650A1 (de) * 1985-05-02 1986-11-06 Biochemie GmbH, Kundl, Tirol Verfahren zur abtrennung von biotechnologisch hergestellten wertstoffen durch querstrom-mikrofiltration
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
DE4204700A1 (de) * 1992-02-17 1993-08-19 Henkel Kgaa Verfahren zur abtrennung anorganischer salze
CN1038512C (zh) * 1992-10-20 1998-05-27 空军第四研究所 促肝细胞生长素生产方法
US5681746A (en) * 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
US5597486A (en) * 1995-05-01 1997-01-28 Millipore Investment Holdings Limited Membrane filtration with optimized addition of second liquid to maximize flux
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6436897B2 (en) * 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
US6245568B1 (en) * 1999-03-26 2001-06-12 Merck & Co., Inc. Human papilloma virus vaccine with disassembled and reassembled virus-like particles
ATE319810T1 (de) * 1999-11-19 2006-03-15 Zycos Inc Durchflussverfahren zur herstellung von mikropartikeln
GB2364052B (en) * 2000-06-27 2003-05-14 Univ London A method and apparatus for producing a biomaterial product
JP2002066273A (ja) * 2000-09-01 2002-03-05 Terumo Corp 中空糸膜の酸化抑制方法
US20050164929A1 (en) * 2000-11-06 2005-07-28 Lupine Logic, Inc. Methods of preventing and treating inflammatory bowel disease
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
JP3815351B2 (ja) * 2002-03-12 2006-08-30 栗田工業株式会社 糖液精製装置及び糖液精製方法
US7314746B2 (en) * 2002-09-13 2008-01-01 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
AU2003287299A1 (en) * 2002-11-01 2004-06-07 Bayer Healthcare Llc Process for concentration of macromolecules
JP4558652B2 (ja) * 2003-06-20 2010-10-06 マイクロビクス・バイオシステムズ・インコーポレイテツド ウイルス生産の改善
US20060083694A1 (en) * 2004-08-07 2006-04-20 Cabot Corporation Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same
US7638491B2 (en) * 2004-12-22 2009-12-29 Ambrx, Inc. Therapies using non-natural amino acids and polypeptides

Also Published As

Publication number Publication date
AR057263A1 (es) 2007-11-28
CR9212A (es) 2007-11-23
EP1841474A2 (en) 2007-10-10
BRPI0607269A2 (pt) 2009-08-25
KR20070101285A (ko) 2007-10-16
CA2594580A1 (en) 2006-08-24
CN101107022B (zh) 2013-07-17
IL184247A (en) 2014-08-31
JP2008528273A (ja) 2008-07-31
US20060194313A1 (en) 2006-08-31
NI200700153A (es) 2008-05-13
KR101337311B1 (ko) 2013-12-06
AU2006215313B2 (en) 2011-11-24
PE20060958A1 (es) 2006-10-27
TW200634145A (en) 2006-10-01
IL184247A0 (en) 2007-10-31
AU2006215313A1 (en) 2006-08-24
RU2007122451A (ru) 2009-03-10
CN101107022A (zh) 2008-01-16
MX2007008777A (es) 2007-10-23
CA2594580C (en) 2013-09-24
RU2442822C2 (ru) 2012-02-20
WO2006087643A2 (en) 2006-08-24
GT200600027A (es) 2006-08-31
JP5312799B2 (ja) 2013-10-09
WO2006087643A3 (en) 2006-11-09
US7906024B2 (en) 2011-03-15

Similar Documents

Publication Publication Date Title
NO20073167L (no) Skjaerbeskyttende midler for isolering ved mikrofiltrering
EA201270716A1 (ru) Макроциклы в качестве ингибиторов фактора xia
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
NO20092053L (no) HCV NS3-proteaseinhibitorer
EP1924593B8 (en) Hcv ns3 protease inhibitors
NO20073098L (no) Substituerte biarylforbindelser som faktor XIa-Inhibitorer
WO2010021717A3 (en) Hcv protease inhibitors
NO20074959L (no) Substituerte pyridinderivater
WO2006119061A3 (en) Hcv ns3 protease inhibitors
WO2008106130A3 (en) Tertiary amine substituted peptides useful as inhibitors of hcv replication
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
DK1828297T3 (da) Fremstilling og behandling af bitumensammensætninger
MX2013002927A (es) Inhibidores del virus de la hepatitis c.
MX2009002740A (es) Inhibidores de renina.
WO2008075376A8 (en) Polymorphic forms of bortezomib and process for their preparation
WO2010056898A3 (en) Rapid expression cloning of human monoclonal antibodies from memory b cells
WO2008036216A8 (en) Piperidine derivatives as renin inhibitors
NO20083405L (no) Nye glycolipidadjuvantsammensetninger
MX2009006750A (es) Derivados de azaadamantano espirociclicos y metodos de uso.
HK1131613A1 (en) Salts of benzimidazolyl pyridyl ethers and formulations thereof
NO20071805L (no) Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.
UA90909C2 (en) Hcv ns3 protease inhibitors
MX2023002234A (es) Proceso.
WO2010056585A3 (en) Heteroaryl diamide compounds useful as mmp-13 inhibitors
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application